Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma

Archives of Surgery

Volumn 136, Issue 5, 2001, Pages 528-535

  Bilimoria, Malcolm M ^a   Lauwers, Gregory Y ^b   Doherty, Dorota A ^a   Nagorney, David M ^c   Belghiti, Jacques ^d   Do, Kim Anh ^a   Regimbeau, Jean Marc ^d   Ellis, Lee M ^a   Curley, Steven A ^a   Ikai, Iwao ^e   Yamaoka, Yoshio ^e   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

^d BEAUJON HOSPITAL   (France)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER RESECTION; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035014082     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.136.5.528     Document Type: Article

References (32)

1. Cancer statistics, 2000
2. Declining cancer rates in the 1990s
3. Primary liver cancer in Japan: Clinicopathologic features and results of surgical treatment
4. Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma
5. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: Is there a way? A prospective analysis of our approach
6. Prognostic factors after hepatectomy for hepatocellular carcinomas: A univariate and multivariate analysis
7. Pathological aspects of hepatocellular carcinoma: A critical review of prognostic factors
8. Resection of hepatocellular carcinomas: Results in 72 European patients with cirrhosis
9. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis
10. Recurrence of hepatocellular carcinoma after surgery
11. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma
12. An analysis of 412 cases of hepatocellular carcinoma at a Western center
13. Histological grading and staging of chronic hepatitis
14. Comparison of outcome between extended and nonextended liver resections for neoplasms
15. The surgical anatomy pertaining to liver resection
16. Regression models for prognostic prediction: Advantages, problems, and suggested solutions
17. Hepatocellular carcinoma and cirrhosis: Results of surgical treatment in a European series
18. Hepatic resection for hepatocellular carcinoma: Clinical features and long-term prognosis
19. Surgery of small hepatocellular carcinoma: Analysis of 144 cases
20. Therapeutic modalities and prognostic factors for primary and secondary liver tumors
21. The role of liver transplantation in hepatobiliary malignancy: A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence
22. Clinicopathologic features of patients with hepatocellular carcinoma surviving 10 years after hepatic resection
23. Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma
24. Long-term results after resection of hepatocellular carcinoma: Experience of 480 cases
25. Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern
26. Importance of field cancerisation in clinical oncology
27. "Field cancerization" in oral stratified squamous epithelium
28. The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: Improved survival of surgically resected patients, 1985-1996
29. Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases
30. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
31. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
32. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma: Hepatoma Prevention Study Group